Publications by authors named "P Shokrani"

Article Synopsis
  • Proton therapy is an advanced cancer treatment that uses precise proton beams to destroy cancer cells while minimizing damage to surrounding healthy tissues.
  • The study investigates the effectiveness of the Geant4 Monte Carlo simulation software, which models the interaction between proton beams and the human body for better treatment planning.
  • By reviewing published articles from 2002 to 2023, researchers found that Geant4 simulations are both reliable and accurate, making them useful for optimizing and assessing proton therapy systems based on real-world experimental data.
View Article and Find Full Text PDF

The stability of dosiomics features (DFs) and dose-volume histogram (DVH) parameters for detecting disparities in helical tomotherapy planned dose distributions was assessed. Treatment plans of 18 prostate patients were recalculated using the followings: field width (WF) (2.5 vs.

View Article and Find Full Text PDF

Background: Glioma is one of the most drug and radiation-resistant tumors. Gliomas suffer from inter- and intratumor heterogeneity which makes the outcome of similar treatment protocols vary from patient to patient. This article is aimed to overview the potential imaging markers for individual diagnosis, prognosis, and treatment response prediction in malignant glioma.

View Article and Find Full Text PDF

Background: Treatment response in High-grade Glioma (HGG) patients changes based on their genetic and biological characteristics. MiRNAs, as important regulators of drug and radiation resistance, and the Apparent Diffusion Coefficients (ADC) value of tumor can be used as a prognostic predictor for glioma.

Objective: This study aimed to identify some of the pre-treatment individual patient features for predicting the treatment response in HGG patients.

View Article and Find Full Text PDF

The aim of this study was to design a predictive radiobiological model of normal brain tissue in low-grade glioma following radiotherapy based on imaging and molecular biomarkers. Fifteen patients with primary brain tumors prospectively participated in this study and underwent radiation therapy. Magnetic resonance imaging (MRI) was obtained from the patients, including T1- and T2-weighted imaging and diffusion tensor imaging (DTI), and a generalized equivalent dose (gEUD) was calculated.

View Article and Find Full Text PDF